CLINICAL TRIALS PROFILE FOR FOSRENOL
✉ Email this page to a colleague
All Clinical Trials for Fosrenol
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00160121 ↗ | Efficacy and Safety of Fosrenol in Treating Elevated Serum Phosphate Levels in Adults With End Stage Renal Disease | Completed | Shire | Phase 4 | 2005-01-10 | The purpose of this study is to test how well lanthanum carbonate reduces the pre-dialysis level of serum phosphorus in subjects undergoing dialysis due to end stage renal disease and to determine the patient and physician's satisfaction. |
NCT00234702 ↗ | Efficacy and Safety of Lanthanum Carbonate in Reducing Serum Phosphorus Levels in Subjects With Stage 3 and 4 Chronic Kidney Disease | Completed | Shire | Phase 2 | 2006-01-11 | Chronic kidney disease (CKD) can result in a loss of ability to filter and excrete phosphate. The body's attempt to adjust to an increased level of phosphate in the blood can result in elevated levels of hormones and minerals resulting in serious clinical consequences. This study is being conducted to evaluate the safety and efficacy of lanthanum carbonate in lowering high levels of phosphorus in the blood in subjects with CKD Stages 3 and 4 compared to placebo. |
NCT00441545 ↗ | Head to Head Study Against Sevelamer Hydrochloride | Completed | Shire | Phase 3 | 2007-01-05 | To compare the efficacy of Fosrenol (Lanthanum carbonate) and sevelamer hydrochloride in the reduction of serum phosphorus levels from baseline. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Fosrenol
Condition Name
Clinical Trial Locations for Fosrenol
Trials by Country
Clinical Trial Progress for Fosrenol
Clinical Trial Phase
Clinical Trial Sponsors for Fosrenol
Sponsor Name